Roche Holding AG ( RHHVF) - Key Metrics
RHHVF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $38.41 | $6.87 | $14.11 | $11.51 |
| 2025Q2 | $38.54 | $9.23 | $4.42 | $3.38 |
| 2024Q4 | $39.78 | $2.54 | $14.69 | $12.42 |
| 2024Q2 | $38.49 | $7.83 | $9.90 | $7.75 |
| 2023Q4 | $36.30 | $5.47 | $9.92 | $6.56 |
RHHVF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | 11.96% | 11.94 |
| 2025Q2 | 52.17% | 7.00 |
| 2024Q4 | ? | 25.16 |
| 2024Q2 | 122.24% | 7.98 |
| 2023Q4 | 0.62% | 11.17 |
RHHVF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | 3.51% | 0.25% |
| 2025Q2 | 1.31% | 1.86% |
| 2024Q4 | 4.86% | ? |
| 2024Q2 | 3.10% | 3.83% |
| 2023Q4 | 2.68% | 0.01% |
RHHVF
Price: $404
Dividend Yield: 2.50%
Forward Dividend Yield: 3.21%
Payout Ratio: 69.86%
Dividend Per Share: 12.79 USD
Earnings Per Share: 20.11 USD
P/E Ratio: 21.83
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: Switzerland
Market Capitalization: 349.5 billion
Average Dividend Frequency: 1
Years Paying Dividends: 37
DGR3: 30.00%
DGR5: 23.68%
DGR10: 12.92%
DGR20: 12.90%